Overall rank by patents
#28,096
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Alembic Pharmaceuticals Limited
USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07D (HETEROCYCLIC COMPOUNDS).
9
Total patents granted
7
CPC technology areas
11.6
Avg claims per patent
-71%
5-year filing velocity
The verdict
Alembic holds 9 US patents across 7 technology areas, rank #28,096 of 50,000 tracked assignees.
- #28,096
- of 50,000 US assignees by volume
- Top 80%
- by Innovation Score (26.5/100)
- 11.6
- avg claims per patent
- -71%
- filing velocity, last 5 yrs
Portfolio overview
Alembic Pharmaceuticals Limited has been granted 9 US utility patents between 2015 and 2023, placing Alembic Pharmaceuticals Limited at rank #28,096 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.6 claims per patent with primary concentration in C07D (HETEROCYCLIC COMPOUNDS). As a Foreign Corporation, Alembic Pharmaceuticals Limited is one of the more focused assignees in the PatentsView dataset. By volume, Alembic sits between Alaska Structures, Inc. (9 patents, rank #28,092) and Ali Industries, Llc (9 patents, rank #28,100) - the closest US assignees by grant volume. The composite Innovation Score of 26.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 7 in the 2015–2019 window, a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Alembic Pharmaceuticals Limited's 11.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Alembic Pharmaceuticals Limited against peers pursuing similar technology classes.
Who files at Alembic's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Alaska Structures
Alaska Structures, Inc.
9 patents
- Albonair
Albonair GmbH
9 patents
- Alchemy Logic Sys…
Alchemy Logic Systems Inc.
9 patents
- Alchemy Sciences
Alchemy Sciences, Inc.
9 patents
- Aletha
Aletha Inc.
9 patents
- Alex Schoemaker L…
Alex Schoemaker Living Creations Holding B.V.
9 patents
- Algipharma AS
AlgiPharma AS
9 patents
- Ali Industries
Ali Industries, LLC
9 patents
- Alembic Pharmaceu… ◀
Alembic Pharmaceuticals Limited
9 patents
What this shows Alembic holds 9 patents at rank #28,096, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Alembic
By rank, the assignees closest to #28,096 in granted patent volume.
- Alaska Structures, Inc. #28,092 · 9 patents
- Albonair Gmbh #28,093 · 9 patents
- Alchemy Logic Systems Inc. #28,094 · 9 patents
- Alchemy Sciences, Inc. #28,095 · 9 patents
- Aletha Inc. #28,097 · 9 patents
- Alex Schoemaker Living Creations Holding B.v. #28,098 · 9 patents
- Algipharma AS #28,099 · 9 patents
- Ali Industries, Llc #28,100 · 9 patents
Leaders in C07D (Heterocyclic Compounds)
Other assignees with the most granted patents in Alembic's primary technology class.
Alembic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
26 Top 80% higher than 20% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 22.2% |
| 2016 | 2 | 22.2% |
| 2018 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
| 2023 | 1 | 11.1% |
Which technologies does Alembic Pharmaceuticals Limited patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Alembic Pharmaceuticals Limited hold?
Alembic Pharmaceuticals Limited holds 9 US granted patents filed between 2015 and 2023, spanning 7 technology areas.
What is Alembic Pharmaceuticals Limited's Innovation Score?
Alembic Pharmaceuticals Limited has an Innovation Score of 26.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Alembic Pharmaceuticals Limited focus on?
Alembic Pharmaceuticals Limited's top technology area is C07D (HETEROCYCLIC COMPOUNDS) with 7 patents. The company has filed patents in 7 CPC subclasses total.
Is Alembic Pharmaceuticals Limited's patent filing rate increasing or decreasing?
Alembic Pharmaceuticals Limited's recent filing velocity is -71% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Alembic Pharmaceuticals Limited's patents?
Alembic Pharmaceuticals Limited's patents average 11.6 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Alembic Pharmaceuticals Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Alembic's 9 grants land it in the top 80% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Alembic ranks #28,096 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C07D - see who else leads that technology area. C07D leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.